1-Hydroxy monocyclic carotenoid 3,4-dehydrogenase from a marine bacterium that produces myxol  by Teramoto, Maki et al.
FEBS Letters 570 (2004) 184–188 FEBS 285941-Hydroxy monocyclic carotenoid 3,4-dehydrogenase from
a marine bacterium that produces myxolMaki Teramotoa,*,1, Nina R€ahlertb,1, Norihiko Misawaa, Gerhard Sandmannb
aMarine Biotechnology Institute, 3-75-1 Heita, Kamaishi-shi, Iwate 026-0001, Japan
bBiosynthesis Group, Botanical Institute, Goethe University, P.O. Box 111932, D-60054 Frankfurt, Germany
Received 8 April 2004; accepted 28 May 2004
Available online 2 July 2004
Edited by Richard CogdellAbstract A crtD (1-HO carotenoid 3,4-dehydrogenase gene)
homolog from marine bacterium strain P99-3 included in the
gene cluster for the biosynthesis of myxol (30,40-didehydro-10,20-
dihydro-b;w-carotene-3,10,20-triol) was functionally identiﬁed.
The P99-3 CrtD was phylogenetically distant from the other
CrtDs. A catalytic feature was its high activity for the
monocyclic carotenoid conversion: 10-HO-torulene (30,40-didehy-
dro-10,20-dihydro-b;w-caroten-10-ol) was prominently formed
from 10-HO-c-carotene (10,20-dihydro-b;w-caroten-10-ol) in
Escherichia coli with P99-3 CrtD, indicating that this enzyme
has been highly adapted to myxol biosynthesis. This unique type
of crtD is a valuable tool for obtaining 10-HO-30,40-didehydro
monocyclic carotenoids in a heterologous carotenoid production
system.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Certain species of bacteria, yeasts and fungi, as well as algae
and higher plants synthesize a large number of carotenoids
with diﬀerent molecular structures. Most natural carotenoid
diversity arises from diﬀerences in the type and level of de-
saturation and other modiﬁcations to the C40 backbone.
Carotenoids have a variety of biological functions such as the
stabilization of membrane ﬂuidity, elimination of free radicals,
photo protection, light harvesting, and as precursors for hor-
mones [1]. Recent discoveries of their beneﬁcial health-related
properties have spurred great interest in the production of
structurally diverse carotenoids for pharmaceutical applica-
tions [2].
Carotenoids are derived from the general isoprenoid (terpe-
noid) pathway. Tail–to-tail condensation of two molecules of
geranylgeranyl pyrophosphate (GGPP) results in the formation
of the ﬁrst C40 carotenoid phytoene. This colorless carotenoid
is converted to lycopene (w;w-carotene), which is a linear red-
colored carotenoid, through four desaturation reactions via* Corresponding author. Fax: +81-193-26-6584.
E-mail address: maki.teramoto@mbio.jp (M. Teramoto).
1 These authors are contributed equally to this study.
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.05.085phytoﬂuene, f-carotene and neurosporene. Cyclization of ly-
copene frequently follows carotene desaturation and precedes
xanthophyll formation in the biosynthetic sequence. In an-
oxygenic photosynthetic bacteria, non-photosynthetic bacteria,
and fungi, phytoene dehydrogenases (CrtI type) introduce
three, four or ﬁve double bonds into phytoene consecutively,
and yield neurosporene, lycopene, and 3,4-didehydrolycopene,
respectively [3–5]. Phytoene dehydrogenases in cyanobacteria,
algae and plants (Pds type) perform two dehydrogenations,
generating f-carotene as the ﬁnal product. f-Carotene dehy-
drogenase is subsequently required for generating lycopene in
those organisms [3–5]. Dehydrogenases designated CrtD dis-
play amino acid sequence similarity to the CrtI-type phytoene
dehydrogenases [6,7] and catalyze the introduction of C-3,4
double bonds into 1-hydroxy carotenoids [8,9]. The crtD genes
have so far been cloned from purple photosynthetic bacteria,
which form acyclic carotenoids [8–11]. The biosynthetic path-
way just described is outlined in Fig. 1.
Marine bacterium strain P99-3 of the family Flavobacteria-
ceae produces myxol as the main carotenoid [13,14], which is a
b-monocyclic carotenoid and is the aglycone of myxoxantho-
phyll commonly distributed in cyanobacteria [15]. The gene
cluster for myxol synthesis has been cloned from strain P99-3
and a crtD homolog was identiﬁed in the cluster [13]. A crtD
gene has never before been isolated from organisms which
produce cyclic carotenoids. This led us to investigate the po-
tential of the P99-3 homolog of CrtD for unique catalytic fea-
tures, which would be beneﬁcial for myxol synthesis and for the
synthesis of diverse monocyclic carotenoids. This report de-
scribes the structural and functional analyses of the P99-3 CrtD.2. Materials and methods
2.1. Bacterial strains, plasmids, oligonucleotides, and growth conditions
The bacterial strains, plasmids and oligonucleotides used in this
study are listed in Table 1. Escherichia coli JM101 was grown on
Luria–Bertani (LB) medium [21] at 28 C. When required, the medium
was supplemented with the following antibiotics at the indicated
concentrations: ampicillin (Ap), 100 lg/ml; chloramphenicol (Cm), 20
lg/ml; tetracycline (Tc), 25 lg/ml; and kanamycin (Km), 25 lg/ml.
IPTG (isopropyl b-D-thiogalactopyranoside) was added to the JM101
transformants containing pSO50, pSO53, or pUCZD to a ﬁnal con-
centration of 0.1 mM when an optical density at 600 nm (OD600) of 0.6
had been reached and growth was allowed to continue for 24 h more.
2.2. Genetic techniques
Standard recombinant DNA techniques were performed as de-
scribed by Sambrook et al. [21].blished by Elsevier B.V. All rights reserved.
Table 1
Bacterial strains and plasmids used in this study
Strain/plasmid Relevant characteristic(s)a
Strain
E. coli JM101 Host strain for heterologous expression of crt gene
Plasmid
pACCRT-EIBEu Cm
r, lycopene-producing plasmid containing crtEI
pACCRT-EBIRc Cm
r, neurosporene-producing plasmid containing c
capsulatus, p15A
pUCZD Apr, crtD from strain P99-3 in pUC18, lacZ::crtD,
pRKcrtC Tcr, crtC from Rba. capsulatus in pRK404, RK2 o
pACCRT-EBIal2 Cmr, c-carotene-producing plasmid, lycopene cycla
pACCRT-EIBEu
pFL104 Apr, crtC from Rba. capsulatus in pBR325
pSO50 Kmr, crtDC from Rubrivivax gelatinosus in pBBR1
pSO53 Kmr, crtD from Rvi. gelatinosus in pBBR1MCS-2,
aApr, ampicillin-resistant; Cmr, chloramphenicol-resistant; Tcr, tetracycline-
Fig. 1. Biosynthetic pathway to lycopene and subsequent cyclic and
acyclic derivatives, and formation of substrate and product carote-
noids involved in the reactions catalyzed by CrtD from strain P99-3
[9,12]. The dashed arrows indicate hypothetical reactions. The func-
tions of the CrtD were experimentally conﬁrmed in this study. E.u
represents Erwinia uredovora; and R.c, Rhodobacter capsulatus.
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Homologous protein sequences in the non-redundant (NR) protein
sequence database were retrieved by using version 2.0 of the BLAST
program [22]. The protein sequences were aligned with ClustalW,
version 1.7 [23], and a neighbor-joining tree was constructed by using
the njplot program in this software. Gaps were included in the calcu-
lations.
2.4. In vivo complementation and analysis of carotenoid pigments
E. coli cells accumulating either a 1-HO-neurosporene, 1-HO-lyco-
pene or 10-HO-c-carotene (10,20-dihydro-b;w-caroten-10-ol) back-
ground were established by transformation with the appropriate
plasmids (Table 1 and Fig. 2). These carotenoid-producing strains were
then co-transformed with plasmid pUCZD. The resulting carotenoids
were extracted with methanol containing 6% KOH from the cells of 50-
ml cultures of the E. coli transformants by heating for 20 min at 60 C
and then partitioned in 50% diethyl ether in petrol. The carotenoid
extracts were evaporated under nitrogen. HPLC analyses were carried
out on either a Nucleosil C 18 column or Hypersil C 18 column at 20
C, using acetonitrile/methanol/2-propanol (85:10:5, v/v/v) as the elu-
ent. The separated carotenoids were detected with a Kontron 440 di-
ode array detector and the resulting absorption spectra were recorded
online. Authentic standards were used to identify the reaction products
of CrtD by co-chromatography, these including various 3,4-desatu-
rated derivatives generated in E. coli as indicated in Fig. 1.3. Results and discussion
3.1. Characteristics of the deduced amino acid sequence
The deduced products of two open reading frames (ORFs)
found in the gene cluster for the myxol synthesis of strain P99-3
showed homology to phytoene dehydrogenase (CrtI type) and
less homology to 1-hydroxy carotenoid 3,4-dehydrogenase
(CrtD) [13]. The product of one ORF, assigned as crtI, showed
phytoene dehydrogenase activity, while that of the other ORF,
designated crtD, did not show this activity [13]. The crtD gene
encodes a protein of 488 amino acid residues [13] with a pre-
dicted molecular mass of 55 kDa. The characteristic amino acid
sequence of ADP-binding bab-fold for FAD or NAD cofactors
[24] is present at the N-terminus of CrtD (residues 3–31). The
residues of an unknown function conserved at the C-termini of
carotenoid dehydrogenases (CrtD and CrtI) from Rba. cap-
sulatus [19] were also found at the C-terminus of the P99-3
CrtD (residues 455–470). Hydropathy analysis of the P99-3
CrtD [25] (http://www.bio.davidson.edu/courses/compbio/
jems/project1page.html#References) did not reveal any puta-
tive transmembrane domains.Reference/source
s Toyobo
B from E. uredovora, p15A origin of replication [16,17]
rtEB from E. uredovora, and crtI from Rba. [18]
pMB1 origin of replication [13]
rigin of replication [8]
se gene al-2 from Neurospora crassa in Unpublished
plasmid; [12]
[19]
MCS-2, REP origin of replication [20]
REP [9]
resistant; Kmr, kanamycin-resistant.
Fig. 2. HPLC elution proﬁles of the carotenoids produced in
hydroxyneurosporene-accumulating E. coli (A), in lycopene- or hy-
droxylycopene-accumulating E. coli (B), and in c-carotene or hydroxy-
c-carotene-accumulating E. coli (C) in the presence of P99-3 crtD. The
carotenoid proﬁles of the hydroxyneurosporene- and hydroxy-c-car-
otene-accumulating cells carrying crtD from Rvi. gelatinosus (R.g) are
also shown (A3, C5). Genes on the plasmids introduced into E. coli
and the carotenoids identiﬁed are indicated. E.u represents E. uredo-
vora; R.c, Rba. capsulatus; P99, strain P99-3; and N.c, N. crassa. The
amount of each hydroxy carotenoid is given as a percentage by weight
of the total hydroxy carotenoids in parentheses next to the peak
numbers (C4, C5). The plasmids contained in the E. coli cells were
pACCRT-EBIRc and pRKcrtC (A1); pACCRT-EBIRc, pRKcrtC and
pUCZD (A2); pACCRT-EBIRc and pSO50 (A3); pACCRT-EIBEu and
pUCZD (B1); pACCRT-EIBEu and pRKcrtC (B2); pACCRT-EIBEu,
pRKcrtC and pUCZD (B3); pACCRT-EBIal2 (C1); pACCRT-EBIal2
and pUCZD (C2); pACCRT-EBIal2 and pFL104 (C3); pACCRT-
EBIal2, pRKcrtC and pUCZD (C4); and pACCRT-EBIal2, pRKcrtC
and pSO53 (C5). Carotenoids were detected with the following
absorbance maxima: 414, 442, 470 nm (Neu, 1-HO-Neu, 1,10-(HO)2-
Neu); 425, 455, 485 nm (DMS, 1-HO-DMS); 440, 470, 505 nm (Lyc,
1-HO-Lyc, 1,10-(HO)2-Lyc); 450, 485, 518 nm (1-HO-3,4-DDL, 1,10-
(HO)2-3,4-DDL); 465, 495, 530 nm (1,1
0-(HO)2-TDL); 430, 460, 490
nm (c-Car, 10-HO-c-Car); 420, 455, 480 nm (b-Car); and 440, 475, 510
nm (10-HO-Tor).
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CrtD
To analyze the catalytic activity and determine suitable
substrates to be eﬃciently converted, CrtD from strain P99-3
was expressed in E. coli transformants with diﬀerent caroten-
oid backgrounds. The carotenoids formed were analyzed by
high performance liquid chromatography (HPLC) (Fig. 2),
and their HPLC retention times and UV–visible absorption
spectra were compared with those of authentic carotenoid
samples. CrtI from strain P99-3 introduces four double bonds
into phytoene and yields lycopene [13], and therefore lycopene
and c-carotene were considered as potential substrates for the
CrtD of P99-3 on the myxol biosynthetic pathway. However,
lycopene and c-carotene were not used as substrates by CrtD
(B1 and C2). When E. coli produced 1-HO and 1,10-(HO)2-
neurosporene (A1), both carotenoids were converted to the
corresponding 3,4-dehydrogenated derivative by P99-3 CrtD
(A2). The same result was observed for 1-HO and 1,10-(HO)2-
lycopene (B3). All these reaction products were identiﬁed using
the corresponding authentic carotenoids produced with the
help of other CrtDs from photosynthetic bacteria (A3; data
not shown for 1-HO-3,4-didehydrolycopene and 1,10-(HO)2-
3,4,30,40-tetradehydrolycopene). 1-Hydroxy neurosporene or 1-
hydroxy lycopene is the major substrate for the CrtDs from
photosynthetic acyclic carotenoid-producing bacteria
(Fig. 2A3) [8,9]. In the complementation with 10-HO-c-caro-
tene and P99-3 crtD, 10-HO-torulene (30,40-didehydro-10,
20-dihydro-b;w-caroten-10-ol) (together with 1-HO-3,
4-didehydrolycopene and 1,10-(HO)2-3,4-didehydrolycopene
from 1-HO- and 1,10-(HO)2-lycopene) accumulated (C4). This
monocyclic carotenoid, found in Spirochaeta aurantia J1 as a
major pigment [26], was identiﬁed by its spectral properties
[26], a retention time slightly shorter than that of 10-HO-c-
carotene and by the utilization of 10-HO-c-carotene upon in-
troducing crtD into E. coli (C3, C4). These data clearly show
that crtD from strain P99-3 encodes a 1-hydroxy carotenoid
converting 3,4-dehydrogenase at the w-end group. The con-
version reactions catalyzed by the P99-3 CrtD are indicated in
Fig. 1.
Although neurosporene is an intermediate in the conversion
of phytoene to lycopene by CrtI [13] and 1,10-(HO)2-lycopene
is not an intermediate on the pathway to myxol, 1-hydroxy
neurosporene and 1,10-(HO)2-lycopene were both eﬃcient
substrates for P99-3 CrtD (Fig. 2A2, B3). However, 10-HO-c-
carotene and 1-HO-lycopene were the preferred substrates for
the P99-3 CrtD (Fig. 2C4). These properties of this unique type
of CrtD must reﬂect the cellular carotenoid biosynthetic
pathway to the untypical monocyclic carotenoid myxol in
strain P99-3 (Fig. 1).3.3. P99-3 CrtD phylogenetically distant from the other CrtDs
To explore the phylogenetic relationships among P99-3 CrtD
and the other CrtDs, an unrooted neighbor-joining tree was
constructed based on the deduced amino acid sequences with
the 7 most similar proteins, these all being CrtI-type phyto-
ene dehydrogenases including 5 probable CrtI-type phytoene
dehydrogenases, and with the 3 kinds of CrtI-type phytoene
dehydrogenases, these being CrtI of Rba. capsulatus (three
desaturations) [27], CrtI of E. uredovora (four desaturations)
Fig. 3. Phylogenetic analysis of the P99-3 CrtD amino acid sequence with the 7 most similar proteins, all other CrtDs and the 3 kinds of CrtI type
phytoene dehydrogenases. The 7 similar proteins (in gray) were retrieved from the NR protein sequence database. Proteins suspected to be CrtI-type
phytoene dehydrogenase or CrtD (1-hydroxy carotenoid 3,4-dehydrogenase) are marked with an asterisk. All CrtDs available in the database are
included. The number shown next to each node indicates the percentage bootstrap value of 100 replicates (only 50% or higher are cited). The scale bar
indicates 0.04 substitution per amino acid site. The origins are as follows (GenBank numbers are shown in brackets): P99-3 [AB097813]; Rba.
capsulatus (CrtI) [X52291]; E. uredovora [D90087]; fungus N. crassa [M57465]; fungus Gibberella fujikuroi [AJ426418] [30]; Oceanobacillus iheyensis
[NC_004193]; Staphylococcus aureus MW2 [NC_003923]; S. aureus Mu50 [NC_002758]; fungus Mucor circinelloides [AJ238028] [7]; Methylobacte-
rium extorquens [AY331188]; Pirellula sp. [NC_005027]; Rba. capsulatus (CrtD) [Z11165] [10]; Rhodobacter sphaeroides [AJ010302] [8]; Rvi. gelati-
nosus [AB034704] [9]; Thiocapsa roseopersicina [AF528191] [11]; Rhodopseudomonas palustris [BX572597]; Rhodospirillum rubrum [AY150801];
uncultured proteobacterium [AE008921].
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Two distinct clusters were apparent in the tree. One of these two
clusters contained all CrtDs except the P99-3 CrtD. The P99-3
CrtD was included in the other cluster composed of CrtI-type
phytoene dehydrogenases. This shows that P99-3 CrtD was
evolutionarily distant from the other CrtDs. Strain P99-3 pro-
duces the b-monocyclic carotenoid, myxol, as the main carot-
enoid [14], while the bacteria from which all crtDs excepting
P99-3 crtD are derived produce acyclic carotenoids [8–11].
3.4. Potential of the P99-3 CrtD for producing a variety of
monocyclic carotenoids including 10-HO-torulene
The catalytic properties of CrtDs from strain P99-3 and
from Rvi. gelatinosus related to the synthesis of cyclic carote-
noids were compared in 10-HO-c-carotene-producing E. coli
(Fig. 2C4,C5). 10-HO-Torulene constituted the main caroten-
oid (40% of the total hydroxylated carotenoids) in E. coli with
P99-3 CrtD, while this carotenoid was a minor catalytic
product (4%) of CrtD from Rvi. gelatinosus. These data indi-
cate that, in contrast to CrtD from Rvi. gelatinosus, the P99-3
CrtD was highly adapted to dehydrogenate at C-3,4 of the 1-
HO monocyclic carotenoid to achieve myxol biosynthesis,
showing that a -ring at the other end of the molecule was
tolerated by the P99-3 CrtD. Other CrtDs from Rvi. gelati-
nosus and from Rba. sphaeroides have been reported to exhibit
only weak 30,40-dehydrogenase activity for 10-HO-c-carotene,
and the CrtD from Rvi. gelatinosus has been reported not to
show this activity for 1,10-(HO)2-lycopene in in vitro experi-
ments [8,9]. Thus, P99-3 crtD must be the only 1-HO mono-
cyclic carotenoid 3,4-dehydrogenase gene with the potential
for the heterologous synthesis of a variety of monocyclic car-
otenoids in combination with other carotenogenic genes. Once
3,4-dehydrogenation has been catalyzed, oxygenation by CrtA
[31] can be a subsequent reaction, and the b-ring may also be
independently hydroxylated by CrtZ [28].In conclusion, the 1-HO carotenoid 3,4-dehydrogenase CrtD
from strain P99-3 was found to be phylogenetically distinct
from the other CrtDs. The most prominent catalytic feature
was its high activity for the monocyclic carotenoid conversion
like 10-HO-c-carotene to 10-HO-torulene. This makes P99-3
crtD gene a valuable tool for the heterologous production
of 10-HO-30,40-didehydro monocyclic carotenoids further
substituted on the -ionone ring or on the acyclic part of the
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